Skip to main content

Management of Dengue Infection

Sweet syndrome (Introduction, Types, Pathophysiology)

 

Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome)

Introduction

Sweet syndrome (SS), or acute febrile neutrophilic dermatosis, was first described by Robert Douglas Sweet in 1964. It is a reactive process characterized by the sudden onset of tender, red-to-purple papules and nodules that often merge to form plaques, usually occurring on the upper extremities, face, or neck. This dermatologic condition is often associated with fever and elevated neutrophil levels in the blood (peripheral neutrophilia).


Sweet syndrome


Sweet syndrome is categorized into three types based on the underlying cause:

1. Classic or Idiopathic Sweet Syndrome

This is the most common form, predominantly affecting young women and often following a mild respiratory illness. It may also be associated with pregnancy, inflammatory bowel disease (IBD), vaccinations, other inflammatory conditions, and infections.

2. Malignancy-Associated Sweet Syndrome

This form occurs alongside an underlying malignancy, sometimes being the first indication of a hidden cancer. It can also present as a paraneoplastic syndrome or as part of an established cancer, most commonly linked with acute myelogenous leukemia and myelodysplastic syndrome.

3. Iatrogenic Sweet Syndrome

 This variant is triggered by certain medications, most notably granulocyte colony-stimulating factor (G-CSF). Other implicated agents include trimethoprim/sulfamethoxazole, minocycline, contraceptives like levonorgestrel/ethinyl estradiol, and all-trans retinoic acid (ATRA). Antineoplastic agents, biologics, and radiotherapy have also been linked to iatrogenic Sweet syndrome.


sweet syndrome


Pathophysiology of Sweet Syndrome

Sweet syndrome is a “neutrophil-mediated hypersensitivity reaction” triggered by factors such as infections, malignancies, drugs, or inflammation. Its hallmark is an abnormal activation of neutrophils, supported by the presence of neutrophilia and the condition’s response to treatments targeting neutrophil function.

Granulocyte colony-stimulating factor (G-CSF) plays a key role by prolonging neutrophil survival and increasing their activity. Elevated G-CSF levels correlate with disease severity, and even in cases with low neutrophil counts, lesions can develop due to heightened neutrophil function. All-trans retinoic acid (ATRA), used in acute promyelocytic leukemia, has also been linked to neutrophil dysfunction in drug-induced cases.

Cytokines, such as IL-1, IL-2, and IFN-γ, contribute to the disease, particularly in malignancy-related forms. Elevated IL-6 levels also track with disease activity, decreasing with corticosteroid treatment.

Genetically, HLA-B54 (in Japanese populations) and chromosome 3q abnormalities are associated with the condition. Mutations in FLT3 have also been linked to Sweet syndrome-like skin disease, and familial cases suggest a genetic predisposition.

Comments

Popular posts from this blog

Pathophysiology of Dengue Infection

Pathophysiology of Dengue Infection Dengue is a mosquito-borne viral infection caused by one of four closely related but antigenically distinct serotypes of the dengue virus: DENV-1, DENV-2, DENV-3, and DENV-4. Dengue virus (DENV) is primarily transmitted by the bite of an infected ‘Aedes’ mosquito, particularly ‘Aedes aegypti’. Another important vector is ‘Aedes albopictus’, though it is generally less efficient in transmission. Dengue fever (DF) ranges from a mild febrile illness to severe forms of the disease, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), which can be fatal if not treated promptly. Understanding the pathophysiology of dengue is essential in managing and preventing the spread of the disease. Transmission and Vector The ‘Aedes’ mosquito is the primary vector for dengue. Female mosquitoes require a blood meal for egg development, and during feeding on an infected host, they acquire the dengue virus. The virus replicates within the mosq...

Malnutrition in Children

Malnutrition in Children: Causes, Impacts, and  Strategies Introduction   Malnutrition refers to a condition where an individual's diet does not provide adequate nutrients for optimal health or includes excessive nutrients causing adverse effects. In children, malnutrition can have severe consequences, as it hinders physical growth, cognitive development, and overall well-being.   Globally, malnutrition remains a critical public health challenge. According to UNICEF, over 45 million children under the age of five suffer from wasting, while 149 million are stunted. At the same time, the rise in childhood obesity affects 39 million children. Addressing malnutrition is vital to securing the future health and prosperity of communities worldwide.     Types and Indicators of Malnutrition in Children   Underweight : This occurs when a child's weight falls significantly below the standard expected for their age, indicating insufficient nutrition over a ...

Solutions to Malnutrition

Malnutrition, a condition caused by an unbalanced diet that lacks essential nutrients, affects millions worldwide, leading to serious health risks and developmental challenges. Addressing malnutrition is crucial for fostering healthier communities and promoting overall social well-being. Here are some key strategies to combat malnutrition effectively:   1. Public Health Initiatives and Policies Public health policies play a significant role in shaping a society’s access to nutritious food and its overall health status. Governments can implement initiatives focused on improving nutritional standards and reducing malnutrition. Examples include: Nutritional Assistance Programs: Programs like food subsidies, food stamps, or free school meal initiatives ensure that low-income individuals, especially children, have access to balanced diets. Fortification of Foods: Adding essential nutrients, such as vitamins and minerals, to commonly consumed foods (like flour, salt, and milk) ca...